Clinical Trials

Cerebral Cavernous Malformations 3, Cerebral Cavernous Malformations 2, Hemangioma, Cavernous, Hemangioma, Capillary, Hemangioma, Cavernous, Central Nervous System

Healthcare-Associated Pneumonia, Pulmonary Arterial Hypertension, Schizophrenia, Treatment-Resistant, Adenoviridae Infections, Anxiety Disorders, Arrhythmias, Cardiac, Autistic Disorder, Bipolar Disorder, Bradycardia, Central Nervous System Infections, Endocarditis, Epilepsy, Headache, Heart Arrest, Heart Failure, Hemophilia A, Herpes Simplex, Hyperaldosteronism, Hypertension, Hypokalemia, Infections, Inflammation, Influenza, Human, Sleep Initiation and Maintenance Disorders, Meningitis, Menorrhagia, Migraine Disorders, Neutropenia, Pain, Pneumonia, Retinitis, Schizophrenia, Seizures, Spasm, Staphylococcal Infections, Urinary Tract Infections, Meningitis, Bacterial, Cytomegalovirus Retinitis, Hemangioma, Capillary, Sepsis, Renal Insufficiency, Chronic, Intraabdominal Infections

Hemangioma, Capillary

Hemangioma, Capillary

Hemangioma, Hemangioma, Capillary

Carcinoma, Hepatocellular, Neoplasm Metastasis, Cholangiocarcinoma, Hemangioma, Capillary, Focal Nodular Hyperplasia

Hemangioma, Capillary

Hemangioma, Capillary